ACROSS Global

Rather than operating as a single centralised CRO, ACROSS Global Alliance is built on an alliance model that connects experienced local partners across more than 90 countries into a unified clinical trial delivery network. This structure allows sponsors to access genuine in-market expertise, regulatory knowledge, and cultural understanding at each site, rather than relying on generalist staff deployed from a central office.

Clinical Trial Management Across Markets

The alliance covers the full trial lifecycle, encompassing study design, site selection, patient recruitment, trial execution, specialised diagnostics, and patient-centric care services. Because each local partner operates within their own established regulatory environment, ACROSS Global is positioned to support complex, multi-country studies with greater agility than traditional CRO models permit. The framework is designed to reduce costs and accelerate timelines without sacrificing quality or compliance standards.

Who ACROSS Global Serves

Sponsors ranging from large pharmaceutical companies to emerging biotech organisations and academic institutions use the ACROSS Global network to enter new markets or scale existing programmes. The cost-effective structure is particularly relevant for organisations managing defined budgets across geographically dispersed studies, where local knowledge directly affects recruitment speed and site performance. The proprietary technology platform supports coordination across the partner network, providing visibility and consistency throughout each programme.

Further information is available at across.global.